Conference Information

About Conference

With a zeal, we are glad to announce the 29^th International Conference on Cancer Research and Oncology (Oncology Congress 2020) organized in collaboration with generous support and cooperation from enthusiastic academicians and Editorial Board Members. Oncology Congress 2020 aims at sharing new ideas and technologies amongst the professionals, industrialists and students from research areas of Oncology. As the premier event, we have developed a program with your interests in mind. We have not only increased the number of opportunities for you to network with colleagues from across the world but also introduced more focused sessions that will feature cutting-edge presentations, special panel discussions, and livelier interaction with industry leaders and experts.

Who Should Attend??

Oncology Congress 2020 Conference is a novel discussion to unite overall recognized scholastic Researchers, Public wellbeing experts, Scientists, Academic researchers, Industry specialists, Scholars in the field of Oncology, Hematology, Surgery, Nursing, Radiology, Paediatrics, Advocacy, etc., to exchange about the state of the Research and Development.

Target Audience:

Scientists
Professors
Students
Nurses
Patient Advocates
Doctors
Oncologists
Radiologists
Chemotherapists
Cancer Institutes
Medical Colleges
Medical Practitioners
Diagnostic Laboratory Professionals
Business Entrepreneurs
Industry professionals
Marketing, Advertising and Promotion Agency Executives

Why Should Attend??

The arranging group assembles eminent speakers covering the most recent advances in the field, fusing differing qualities in each sense. We likewise incorporate talks on most recent methodologies for concentrating these biological inquiries.

Exclusive B2B meetings, Interactive Sessions, Panel Discussions, Keynote Sessions, Poster Presentations, Oral Presentations, Workshops, Exhibitions etc., are the main highlights of this event.

Benefits:

All accepted abstracts will be published in the supported journals and Conference Book Proceeding.
Opportunity to conduct Workshop with your team members
Networking with Keynote Speakers, OCM and Eminent personalities for the future course of work.
Opportunity to chair a session.
Individual Speaker Page will be created to get more visibility for your scientific research.
Huge Benefits on Group Registration and much more.

Session/Tracks

Track 1: Oncology

The branch of medicine dealing with the prevention, diagnosis, and treatment of cancer is referred to as Oncology. Cancer is the abnormal and uncontrollable growth of a cell, which does not obey the body's control mechanism and grow out of control, forming new, abnormal cells. Different types of cancer prevail, behaving differently despite of their characteristics to grow, divide & re-divide.

Related Conferences: 6th Asia Pacific Congress of Interventional Oncology, October 2- 5, 2019, Kuala Lumpur, Malaysia | The 12th Annual Royal Marsden Breast Cancer Meeting, October 4, 2019, London, UK | European Congress on Clinical Oncology, October 5, 2019, Frankfurt, Germany | Seed and Soil: Mechanisms of Metastasis, October 7- 9, 2019, Berlin, Germany | 2nd Annual Advances in Immuno-Oncology USA Congress, October 8- 9, 2019, San Diego, USA | 39th Congress of the European Society of Surgical Oncology, October 9- 11, 2019, Rotterdam, The Netherlands | The Royal Marsden Kidney & Prostate Cancer Meeting: Dilemmas from Diagnosis to Treatment, October 11, 2019, London, UK

Track 2: Oncology and its specialties

The 3 major specialties of oncology are:

Medical oncology
Surgical oncology
Radiation oncology

There are several sub-specialties in the field of Oncology. The above mentioned specialties deal with the treatment of cancer through Chemotherapy or Immunotherapy, Biopsies and Radiology respectively. Other sub-specialties are as follows:

Neuro-oncology
Ocular oncology
Head & Neck Oncology
Thoracic Oncology
Breast Oncology
Gastrointestinal Oncology
Bone & Musculoskeletal oncology
Dermatological oncology
Genitourinary Oncology
Gynecologic oncology
Pediatric oncology
Hemato oncology
Preventive oncology
Geriatric oncology
Pain & Palliative oncology
Molecular oncology
Oncopathology
Nuclear medicine oncology
Psycho-oncology
Veterinary oncology

Related Conferences: Cancer Stem Cells: Advances in Biology and Clinical Translation, October 13- 17, 2019, Hong Kong, China | 2019 Cancer Research & Therapy Conference, October 14- 16, 2019, Orlando, USA | 8th InterAmerican Oncology Conference, October 17- 18, 2019, Buenos Aires, Argentina | IV International Conference on Cancer Research & Drug Development, October 21- 23, 2019, Baltimore, USA | 51st Annual Congress of the International Society of Paediatric Oncology, October 23-26, 2019, Lyon, France | 12th International Congress on Myeloproliferative Neoplasms, October 24- 25, 2019, New York, USA | 17th Annual School of Breast Oncology, October 31- November 2, 2019, Atlanta, USA

Track 3: Oncologists- Types and roles

An oncologist is a medical professional who practices oncology and treats cancer providing medical care for a person diagnosed with cancer.

An oncologist manages a patient’s care throughout the course of the disease starting with the diagnosis. The roles include: Explaining the cancer diagnosis and stage, Talking about the treatment options and their preferred choice, Delivering quality and compassionate care, Helping the patient in managing the symptoms and side effects of cancer and the treatment. Following are a few of the types:

Medical Oncologist
Surgical Oncologist
Radiation Oncologist
Gynecologic Oncologist
Pediatric Oncologist
Haematologist-Oncologist

Related Conferences: Molecular Analysis for Personalised Therapy Congress 2019, November 7- 9, 2019, London, UK | The 11th Annual Head and Neck Conference: 'Head and Neck cancer management in the elderly', November 8, 2019, London, UK | Goodbye Flat Biology: Advancing 3D-based Models for Cancer Biology and Drug Discovery, November 10- 13, 2019, Berlin, Germany | A User Guide to Cancer Immunotherapy, November 13, 2019, London, UK | Advanced Breast Cancer 5th ESO-ESMO International Consensus Conference, November 14- 16, 2019, Lisbon, Portugal | The Sixth Royal Marsden Lung Cancer Symposium, November 20, 2019, London, UK | The Royal Marsden Haemato-Oncology Study Day, November 25, 2019, London, UK

Track 4: Medical Oncology

Medical oncologists are doctors who diagnose, assess, treat and manage cancer patients and conduct research that has practical applications. They aim to provide the best possible outcome for cancer patients, whether that is cure, or palliation and prolongation of good quality life. They provide counselling for patients and their families.

Diagnosing cancers, discussing treatment options with patients, arranging and supervising drug treatment and therapies, supporting patients and overseeing their care, including their lives after treatment are part of their roles.

Medical oncologists treat patients whose cancer has potentially been cured by surgery but for whom further therapy improves their outlook.

Medical oncologists treat conditions such as colorectal cancer, breast cancer, lung cancer, ovarian cancer, urological cancers, leukaemia, and melanoma. Common procedures include chemotherapy, endocrine therapy and biological therapies such as antibodies, small molecules and immunotherapy.

Track 5: Clinical Oncology

Clinical oncologists are doctors who treat patients with a balance of radiotherapy and chemotherapy. They are involved in the management of all types of cancer and use a range of other treatments to treat cancers, without using surgery.

They are different than medical oncologists, who use non-radiological treatments for cancer. Clinical oncologists determine which treatment to use by considering a range of factors such as the type of tumour, tumour site, the stage of the disease and the patient’s general health. They assess the relative merits of different treatments before presenting these to the patient.

It is the clinical oncologist that the patient can ask the important questions regarding their condition and treatment.

Track 6: Cancer Research and Advocacy

Research helps to identify causes and develop strategies for prevention, diagnosis, treatment, and cure for cancer. Research centres, institutes, companies, and hospitals, all contribute in a step by step progress against cancer.

Ranging from molecular bioscience to the clinical trials, Cancer research helps in evaluation and comparison of applications of various Cancer treatments. Surgery, radiation therapy, chemotherapy, hormone therapy, immunotherapy and combined treatment modalities such as chemo-radiotherapy are such applications. It is the mid-1990s that marked the shifting of clinical cancer research to therapies derived from biotechnology research, such as cancer immunotherapy and gene therapy.

An advocate is a professional who supports or defends a cause. Similarly, in the cancer community, an advocate supports a cause or policy regarding cancer. Cancer advocates work on a local or national level, providing support to those living with cancer, raising public awareness of the disease, advancing cancer research, improving the quality of cancer care, addressing legislative and regulatory issues that affect cancer research.

Track 7: Drug Design and Clinical Trials

Drug design is a process to find or to search new medicament depending on the biological targets. The drug which is a small molecule affects the biomolecules by activating or inhibiting the function, giving beneficial effect to the individuals. The design of the drug should be complementary to the target in shape and charge so that they can interact and bind with the receptor. It can be computerised as a whole or aided by drug design. This is useful in the search or finding of the drug based on the computational methods, which can be selected by improved affinity, stability and selectivity.

The long process that begins in a research lab ends up with Clinical Trials. It is a research study that involves volunteers. After long years of research works in order to understand its effects on cancer cells in the lab and in animals, a new treatment is used for people in clinical trials. Clinical Trials help doctors to find better treatments and ways to prevent cancer and other diseases. They also help to answer other questions, such as how to prevent disease or manage symptoms and side effects.

Track 8: Cancer Drugs and Vaccines

Cancer drugs have been classified into several classes which include natural products, alkylating agents, hormones, antimetabolites. Vaccine is administered to the healthy people for prevention from certain bacteria or viruses which spread certain diseases. These vaccines protect from the particular bacteria causing disease, as an individual need to be vaccinated before getting infected by the same virus or bacteria so that it is recognized by the immune system easily due to the presence of the specific antigens and thus can be killed or destroyed.

Nitrogen Mustard
5-fluorouracil
HPV vaccine
Hepatitis B vaccine

Track 9: Cancer Diagnostics and Staging

Cancer is suspected in a view of a person’s symptoms and screening tests. Diagnostic tests affirm that Cancer is present which is followed by staging. Staging is a way of analysing the tumour, size, location and the required treatment depending on the Cancer stage. It helps to determine the Prognosis of the patient i.e., treatment predictions, disease outcomes and patients recovery chances.

Track 10: Cancer Treatment, Therapies and Nursing

Earlier treatments focused on surgical techniques for removing tumors. The 1900s marked the beginning of Radiation therapy and Chemotherapeutics which were later refined throughout the 20th century. These non-surgical methods include Medical, Clinical and Radiation Oncology.

Emerging topics in cancer treatment research include:

Anti-cancer vaccines
Newer forms of chemotherapy
Gene therapy
Photodynamic therapy
Radiation therapy
Reoviridae (Reolysin drug therapy)
Targeted therapy
Natural killer cells can induce immunological memory

Oncology nursing care is an important aspect in the treatment of cancer which meets the various needs of oncology patients including appropriate screenings, preventive practices, symptom management, and care to maintain as much normal functioning as possible, and supportive measures upon the end of life.

Oncology nurses can work in hospitals, hospice services, or in physician offices in a variety of specialties such as radiation, surgery, paediatric, or gynaecologic. Oncology nurses have advanced knowledge of assessing the client’s status which helps the multi-disciplinary medical team to develop a treatment plan.

Track 11: Cancer Care and management

Cancer treatment is complex, and managing all of the different aspects of treatment can be stressful. There are different doctors to consult, many tests to schedule, and instructions relating to the care to understand.

Track 12: Biomedical Advancements In Cancer

Biomedical Instruments are designed to aid in the diagnosis, monitoring or treatment of medical conditions. Several new types of equipment are used in the treatment of cancer such as:

Linear Accelerator (LINAC) – It emits radiation of highly localised (X-rays) and it is useful in the treatment of cancer. The 6 MeV linear accelerator having the capability of surface electron allows treating cancer cells even under the subcutis layer overlying the cranium. The patient can also see his activity through the connected display unit.

Gamma Camera – It is used in the detection of cancer via gamma rays. Here tracers used are introduced into the patient’s body intravenously, thus getting the image on the gamma camera as the tracer emits gamma rays which are detected by the gamma camera.

Radiography and Ultrasound – It is a non-invasive way of getting the image of the internal organs by ultrasound. It is a useful method for cancer patients for examining the abdomen for any enlargement of the lymph or masses.

Track 13: Case Study Reports

A case study is a research method involving an up-close, in-depth, and detailed examination of a concerned case (subject/topic), as well as its related contextual conditions. Case studies can be produced by a formal research method followed by an individual, organization, event, or action, existing in a specific time and place. Here we are inviting case studies based on any types of cancer or related incidents or events with facts and figures. Presenting your studies on any other type of cancer in this category will privilege you with a 30% discount on registration.

Track 14: Prevention and Healthy Living

Cancer Prevention and risk-reduction strategies greatly lower the physical, emotional, and financial burden of cancer and improve the overall health of cancer survivors, including lowering the risk of the formation of second cancer.

It is also notable that although the risk of developing cancer can be greatly reduced by avoiding risk factors, not all cancers are preventable.

Track 15: Coping with Cancer

Along with the treatment, there are several factors that affect a patient and the family. Coping with cancer involves the process of management or care at each stage of the condition including the screening of Cancer, Cancer Treatment and after cure effect, etc., It includes physical, emotional, and financial factors.

Managing Emotions
Talking With Family and Friends
Caring for a Loved One
Hearing the Oncologists' Perspective
Managing Stress
Coping with Guilt
Fear of Treatment-Related Side Effects
Grief and Loss

Market Analysis

Cancer is a disease characterized by uncontrolled cell proliferation. There are more than 100 types of cancer. The most common causes of cancer death are cancers of Lung (1.69 million deaths), Liver (788 000 deaths), Colorectal (774 000 deaths), Stomach (754 000 deaths) and Breast (571 000 deaths) which accounts for nearly half of new cases per year. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.

The kinds of cancer we expect to increase the most are

· Melanoma (the deadliest kind of skin cancer) in white men and women.

· Prostate, kidney, liver, and bladder cancers in men.

· Lung, breast, uterine, and thyroid cancers in women.

Cancer is among the leading causes of death worldwide. In 2012, there were 14.1 million new cases and 8.2 million cancer-related deaths worldwide. The number of new cancer cases per year is expected to rise to 23.6 million by 2030. The most recent SEER Cancer Statistics Review, released in April 2018, shows that cancer death rates decreased by 1.8% per year among men from 2006 to 2015, 1.4% per year among women from 2006 to 2015 and 1.4% per year among children ages 0–19 from 2011 to 2015.

Global Oncology/ Cancer Drugs Market is expected to garner $111,938.4 million by 2020, registering a CAGR of 7.1% during the forecast period 2014 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for cancer treatment with the identification of tumour cell specific genes. The number of approved cancer therapies continues to rise. The continued rise and impact of immuno-oncology has been largely centred on the PD-1 and PD-L1 checkpoint inhibitors, which have broad efficacy across solid tumours and are used across 23 different tumour types. Overall, the global market for oncology therapeutic medicines will reach as much as $200 billion by 2022, averaging 10—13% growth over the next five years, with the U.S. market reaching as much as $100 billion by 2022, averaging 12–15% growth.

29^th International Conference on
Cancer Research and Oncology

Quick Links

Theme: Comprehending the aspects of Oncology

Conference Information

About Conference

Session/Tracks

Market Analysis

View Proceedings of Previous Conferences